CoChat

Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers

Open access

The DOI matches its Crossref record, with a small difference in title or year; 12 of the 12 references it cites were found in a registry or an index.

Abstract

A diagnosis of pancreatic cancer is devastating owing to its poor prognosis, with a 5-year survival rate of only 9%. Currently, most individuals are diagnosed at a late stage when treatment options are limited. Early detection of pancreatic cancer provides the greatest hope for making substantial improvements in survival. The Kenner Family Research Fund in partnership with the American Pancreatic Association has sponsored a series of fora to stimulate discussion and collaboration on early detection of pancreatic cancer. At the first forum in 2014, “Early Detection of Sporadic Pancreatic Cancer Summit Conference,” a strategic plan was set forth by an international group of interdisciplinary scientific representatives and subsequently The Strategic Map for Innovation was generated. The current conference report is the third forum in the series, “Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers,” which was held in Boston, Massachusetts, on October 27, 2016. This report provides an overview of examples of innovative initiatives by industry and confirms the critical need for collaboration among industry, government, research institutions, and advocacy groups in order to make pancreatic cancer more easily detectable in its earlier stages, when it is more treatable.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mpa.0000000000000939

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Strategic map for innovation (copyright Kenner Family Research Fund, 2015).
FIGURE 1 Strategic map for innovation (copyright Kenner Family Research Fund, 2015).CC BY-NC-ND · PubMed Central
FIGURE 2 Phases of biomarker discovery and validation.9,10
FIGURE 2 Phases of biomarker discovery and validation.9,10CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 24

Metadata

Authors
Kenner, B. J., Go, V. L. W., Chari, S. T., Goldberg, A. E., & Rothschild, L. J.
Affiliations
Mayo Clinic (US)
Corresponding author
  • Kenner, Barbara J.
  • Goldberg, Ann E.
  • Rothschild, Laura J.
Venue
Pancreas
Published
2017-11
Volume
46
Issue
10
Pages
1238-1241
ISSN
  • 0885-3177 (ISSN-L)
  • 1536-4828
OpenAlex
W2759631471
Cited by
24
References
12
Citations by year
2025: 1 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 5
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • Pancreas (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Division of Cancer Prevention, National Cancer Institute
  • Cedars-Sinai Medical Center
  • National Cancer Institute
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
pancreatic cancer, early detection, biomarkers, industry partnerships, strategic planning, interdisciplinary collaboration, cancer screening
MeSH terms
Congresses as Topic, Cooperative Behavior, Diffusion of Innovation, Drug Industry, Humans, International Cooperation, Pancreatic Neoplasms, Biomarkers, Tumor, Molecular Diagnostic Techniques, Biomedical Research, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers. https://app.cochat.ai/papers/10.1097/mpa.0000000000000939
The paper
Kenner, B. J., Go, V. L. W., Chari, S. T., Goldberg, A. E., & Rothschild, L. J. (2017). Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers. Pancreas. https://doi.org/10.1097/mpa.0000000000000939

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.